scholarly journals Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members

2007 ◽  
Vol 16 (2) ◽  
pp. 52-65 ◽  
Author(s):  
Ronald C. Kessler ◽  
Lenard A. Adler ◽  
Michael J. Gruber ◽  
Chaitanya A. Sarawate ◽  
Thomas Spencer ◽  
...  
2014 ◽  
Vol 69 (3) ◽  
pp. 216-223 ◽  
Author(s):  
Karin Sonnby ◽  
Konstantinos Skordas ◽  
Susanne Olofsdotter ◽  
Sofia Vadlin ◽  
Kent W. Nilsson ◽  
...  

2017 ◽  
Vol 23 (10) ◽  
pp. 1170-1177 ◽  
Author(s):  
Andreas Lundin ◽  
Kyriaki Kosidou ◽  
Christina Dalman

Objective: The World Health Organization (WHO) Adult ADHD Self-Report Scale (ASRS) is intended to measure population prevalence of ADHD. The short version ASRS-6 has yet not been validated in a population setting. Our aim was to examine the validity of the ASRS-6 in a general population. Method: We used the Stockholm Public Health Cohort 2014. The convergent validity was assessed using item response theory (IRT). The discriminant validity was assessed by examining the correlation between the ASRS and known correlates. Results: The ASRS-6 was unidimensional albeit with hyperactivity and impulsivity items fitting less good. IRT analysis showed that the item difficulty ranged between easy to hard and that the four items on inattention had good or very good discriminatory ability. Correlates were all in the expected direction. Conclusion: The ASRS-6 has adequate validity in the general population but reflects the duality of ADHD having both inattention and hyperactivity/impulsivity as sufficient and non-necessary criteria.


2005 ◽  
Vol 35 (2) ◽  
pp. 245-256 ◽  
Author(s):  
RONALD C. KESSLER ◽  
LENARD ADLER ◽  
MINNIE AMES ◽  
OLGA DEMLER ◽  
STEVE FARAONE ◽  
...  

Background. A self-report screening scale of adult attention-deficit/hyperactivity disorder (ADHD), the World Health Organization (WHO) Adult ADHD Self-Report Scale (ASRS) was developed in conjunction with revision of the WHO Composite International Diagnostic Interview (CIDI). The current report presents data on concordance of the ASRS and of a short-form ASRS screener with blind clinical diagnoses in a community sample.Method. The ASRS includes 18 questions about frequency of recent DSM-IV Criterion A symptoms of adult ADHD. The ASRS screener consists of six out of these 18 questions that were selected based on stepwise logistic regression to optimize concordance with the clinical classification. ASRS responses were compared to blind clinical ratings of DSM-IV adult ADHD in a sample of 154 respondents who previously participated in the US National Comorbidity Survey Replication (NCS-R), oversampling those who reported childhood ADHD and adult persistence.Results. Each ASRS symptom measure was significantly related to the comparable clinical symptom rating, but varied substantially in concordance (Cohen's κ in the range 0·16–0·81). Optimal scoring to predict clinical syndrome classifications was to sum unweighted dichotomous responses across all 18 ASRS questions. However, because of the wide variation in symptom-level concordance, the unweighted six-question ASRS screener outperformed the unweighted 18-question ASRS in sensitivity (68·7% v. 56·3%), specificity (99·5% v. 98·3%), total classification accuracy (97·9% v. 96·2%), and κ (0·76 v. 0·58).Conclusions. Clinical calibration in larger samples might show that a weighted version of the 18-question ASRS outperforms the six-question ASRS screener. Until that time, however, the unweighted screener should be preferred to the full ASRS, both in community surveys and in clinical outreach and case-finding initiatives.


2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Kristin B. Highland ◽  
Rebecca Crawford ◽  
Peter Classi ◽  
Ross Morrison ◽  
Lynda Doward ◽  
...  

Abstract Background Pulmonary arterial hypertension (PAH) is characterized by progressive limitations on physical activity, right heart failure, and premature death. The World Health Organization functional classification (WHO-FC) is a clinician-rated assessment used widely to assess PAH severity and functioning, but no equivalent patient-reported version of PAH symptoms and activity limitations exists. We developed a version of the WHO-FC for self-completion by patients: the Pulmonary Hypertension Functional Classification Self-Report (PH-FC-SR). Methods Semistructured interviews were conducted with three health care providers (HCPs) via telephone to inform development of the draft PH-FC-SR. Two rounds of semi-structured interviews were conducted with 14 US patients with a self-reported PAH diagnosis via telephone/online to elicit concepts and iteratively refine the PH-FC-SR. Results HCPs reported that the WHO-FC was a useful tool for evaluating patients’ PAH severity over time and for making treatment decisions but acknowledged that use of the measure is subjective. Patients in round 1 interviews (n = 6) reported PAH symptoms, including shortness of breath (n = 6), fatigue (n = 5), syncope (n = 5), chest pains (n = 3), and dizziness (n = 3). Round 1 patients identified challenges with the original WHO-FC, including comprehensibility of clinical terms and overlapping descriptions of class II and III, and preferred the Draft 1 PH-FC-SR over the original WHO-FC. After minor changes were made to Draft 2, round 2 interviews (n = 8) confirmed patients understood the PH-FC-SR class descriptions, interpreting them consistently. Conclusions The HCP and patient interviews identified and confirmed certain limitations inherent within the clinician-rated WHO-FC, including subjective assessment and overlapping definitions for class II and III. The PH-FC-SR includes patient-appropriate language, symptoms, and physical activity impacts relevant to patients with PAH. Future research is recommended to validate the PH-FC-SR and explore its correlation with the physician-assessed WHO-FC and other outcomes.


Sign in / Sign up

Export Citation Format

Share Document